↓ Skip to main content

The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer

Overview of attention for article published in Frontiers in oncology, August 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
Published in
Frontiers in oncology, August 2021
DOI 10.3389/fonc.2021.697626
Pubmed ID
Authors

Carina Mucciolo Melo, Huawei Wang, Ken Fujimura, Jan Strnadel, Maria Cecília Zorél Meneghetti, Helena Bonciani Nader, Richard L. Klemke, Maria Aparecida Silva Pinhal

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 17%
Student > Doctoral Student 2 11%
Unspecified 1 6%
Other 1 6%
Student > Master 1 6%
Other 0 0%
Unknown 10 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 22%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unspecified 1 6%
Chemistry 1 6%
Engineering 1 6%
Other 0 0%
Unknown 10 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2021.
All research outputs
#23,885,769
of 26,588,416 outputs
Outputs from Frontiers in oncology
#16,902
of 23,330 outputs
Outputs of similar age
#383,217
of 444,389 outputs
Outputs of similar age from Frontiers in oncology
#844
of 1,343 outputs
Altmetric has tracked 26,588,416 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,330 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,389 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,343 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.